GeneDx Holdings Corp.
WGS
$108.35
$6.756.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 99.82M | 85.76M | 94.20M | 77.42M | 69.44M |
| Total Other Revenue | 2.87M | 1.36M | 1.44M | -544.00K | 1.08M |
| Total Revenue | 102.69M | 87.12M | 95.64M | 76.87M | 70.51M |
| Cost of Revenue | 31.79M | 28.64M | 29.44M | 29.04M | 27.56M |
| Gross Profit | 70.90M | 58.48M | 66.21M | 47.84M | 42.95M |
| SG&A Expenses | 46.86M | 50.45M | 43.48M | 43.17M | 42.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 785.00K | 774.00K | -- |
| Total Operating Expenses | 93.73M | 91.67M | 85.14M | 84.65M | 81.09M |
| Operating Income | 8.96M | -4.55M | 10.50M | -7.77M | -10.58M |
| Income Before Tax | 10.56M | -6.08M | 5.41M | -8.36M | -29.36M |
| Income Tax Expenses | -246.00K | 447.00K | -24.00K | -47.00K | -190.00K |
| Earnings from Continuing Operations | 10.81M | -6.53M | 5.44M | -8.31M | -29.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.81M | -6.53M | 5.44M | -8.31M | -29.17M |
| EBIT | 8.96M | -4.55M | 10.50M | -7.77M | -10.58M |
| EBITDA | 15.15M | 1.13M | 15.16M | -1.85M | -5.36M |
| EPS Basic | 0.38 | -0.23 | 0.20 | -0.31 | -1.10 |
| Normalized Basic EPS | 0.25 | -0.14 | 0.45 | -0.19 | -0.69 |
| EPS Diluted | 0.36 | -0.23 | 0.20 | -0.31 | -1.10 |
| Normalized Diluted EPS | 0.24 | -0.14 | 0.45 | -0.19 | -0.69 |
| Average Basic Shares Outstanding | 28.58M | 28.15M | 27.78M | 27.10M | 26.62M |
| Average Diluted Shares Outstanding | 29.75M | 28.15M | 27.78M | 27.10M | 26.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |